HOME > News Releases

News Releases

2015.01.14
Corporate
PDF/165KB
Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda
2015.01.07
R&D
PDF/196KB
Sunovion Pharmaceuticals Inc. Announces FDA Acceptance for Review of Supplemental New Drug Application for the Use of Aptiom (eslicarbazepine acetate) as Monotherapy Treatment for Partial Onset Seizures
2014.12.26
Corporate
PDF/165KB
Sumitomo Dainippon Pharma Announces Reorganization of Production Sites
2014.12.25
R&D
PDF/176KB
Sumitomo Dainippon Pharma Announces Preliminary Findings from a Phase III Clinical Study (PASTEL Study) of Lurasidone, an Atypical Antipsychotic Agent, in the Treatment of Patients with Schizophrenia
2014.12.11
R&D
PDF/171KB
Investigational Drug Dasotraline Significantly Improved Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in a Placebo-Controlled Study in Adults
2014.11.18
Products
PDF/219KB
Sumitomo Dainippon Pharma obtains Approval in Japan for Partial Change of the Approved Indication to “Type 2 Diabetes” for SUREPOST, a Rapid-acting Insulin Secretagogue
More News Releases

Page Top